NVRI (NVRI) insider files Form 144 to sell 9,692 common shares

Rhea-AI Filing Summary

An affiliate of NVRI filed a Form 144 notice to sell up to 9,692 common shares through UBS Financial Services Inc. on the NYSE. The filing lists an aggregate market value of 176,103 for these shares, compared with 80,652,661 shares outstanding of the same class.

The shares to be sold were acquired from the issuer through restricted stock releases on 03/04/2023, 03/04/2024, and 03/07/2024, and through a stock appreciation right (SAR) exercise on 12/08/2025. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	9692	176103	80652661	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	03/04/2023	Restricted Stock Release	Issuer			848	03/04/2023	n/a
common	03/04/2024	Restricted Stock Release	Issuer			848	03/04/2024	n/a
common	03/07/2024	Restricted Stock Release	Issuer			3727	03/07/2024	n/a
common	12/08/2025	SAR exercise	Issuer			4269	12/08/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NVRI Form 144 filing disclose?

The Form 144 filing for NVRI discloses a planned sale of up to 9,692 shares of common stock on the NYSE, with an aggregate market value of 176,103, using UBS Financial Services Inc. as broker.

How many NVRI shares are outstanding compared to the amount being sold?

The filing states that 80,652,661 shares of the same class of NVRI common stock are outstanding, compared to the 9,692 shares covered by this Form 144 notice.

How were the NVRI shares in this Form 144 acquired?

The shares were acquired from the issuer through restricted stock releases on 03/04/2023, 03/04/2024, and 03/07/2024, and via a SAR exercise (stock appreciation right exercise) on 12/08/2025.

When is the planned sale date for the NVRI shares in this Form 144?

The filing lists an approximate date of sale of 12/08/2025 for the 9,692 NVRI common shares covered by the notice.

Which broker and exchange are involved in this NVRI Form 144 sale?

The Form 144 indicates that the common shares are to be sold through UBS Financial Services Inc., with trading on the NYSE as the named securities exchange.

What representation does the seller make in the NVRI Form 144 filing?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.